Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11798)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 28, 2017 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Song JE, Kim DY. Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma. World J Hepatol 2017; 9(18): 808-814 [PMID: 28706579 DOI: 10.4254/wjh.v9.i18.808] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i18/808.htm |
| Number | Citing Articles |
| 1 |
Mina S. Makary, Luis E. Regalado, Jonathan Alexander, Vineeth Sukrithan, Bhavana Konda, Jordan M. Cloyd. Clinical Outcomes of DEB-TACE in Hepatic Metastatic Neuroendocrine Tumors: A 5-Year Single-Institutional Experience. Academic Radiology 2023; 30: S117 doi: 10.1016/j.acra.2023.03.042
|
| 2 |
Qian-qian Du, Min Liang, Bo Jiang, Miao Zhang, Xiao-ling Yu, Xiao Li, Jia-hu Hao. Incidence and predictors of abdominal pain after transarterial chemoembolization of hepatocellular carcinoma: a single-center retrospective study. European Journal of Oncology Nursing 2023; 66: 102355 doi: 10.1016/j.ejon.2023.102355
|
| 3 |
Thomas J. Vogl, Hamzah Adwan, Leonard Wolff, Maximilian Lahrsow, Tatjana Gruber-Rouh, Nour-Eldin Abdelrehim Nour-Eldin, Jörg Trojan, Wolf-Otto Bechstein, Nagy N. N. Naguib. Retrospective Long-Term Evaluation of Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma over 20 Years. Cancers 2024; 16(8): 1498 doi: 10.3390/cancers16081498
|
| 4 |
Shaikh Afaq, Jayesh M. Soni, Anil K. Pillai. Liver Diseases. 2020; : 687 doi: 10.1007/978-3-030-24432-3_63
|
| 5 |
Davide Ippolito, Cesare Maino, Marco Gatti, Paolo Marra, Riccardo Faletti, Francesco Cortese, Riccardo Inchingolo, Sandro Sironi. Radiological findings in non-surgical recurrent hepatocellular carcinoma: From locoregional treatments to immunotherapy. World Journal of Gastroenterology 2023; 29(11): 1669-1684 doi: 10.3748/wjg.v29.i11.1669
|
| 6 |
Hao Li, Chao Liang, Donglin Kuang, Guohao Huang, Mengfan Zhang, Pengfei Chen, Qingzhu Zheng, Wenze Xu, Jianzhuang Ren, Xinwei Han, Xuhua Duan. The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma. Cancer Biology & Therapy 2023; 24(1) doi: 10.1080/15384047.2023.2166335
|
| 7 |
Francois H. Cornelis, Stephen B. Solomon. Treatment of Primary Liver Tumors and Liver Metastases, Part 2: Non–Nuclear Medicine Techniques. Journal of Nuclear Medicine 2018; 59(12): 1801 doi: 10.2967/jnumed.116.186379
|
| 8 |
Hai-Dong Zhu, Xiao Li, Jun-Hui Sun, Xu Zhu, Zhao-Yu Liu, Hai-Liang Li, Jian Lu, Zhi-Ping Yan, Guo-Liang Shao, Xiao-Feng He, Min Chao, Li-Gong Lu, Bin-Yan Zhong, Rui Li, Qi Zhang, Gao-Jun Teng. Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial). CardioVascular and Interventional Radiology 2024; 47(3): 325 doi: 10.1007/s00270-024-03666-4
|
| 9 |
Abhishek Bansal, Arvind Chaturvedi. Interventional Radiological Management of Hepatocellular Carcinoma. Indian Journal of Medical and Paediatric Oncology 2020; 41(04): 484 doi: 10.4103/ijmpo.ijmpo_256_19
|
| 10 |
Hua Xiang, Lin Long, Yuanhui Yao, Zhiyong Fang, Zhiming Zhang, Yongjin Zhang. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2019; 18 doi: 10.1177/1533033819830751
|
| 11 |
John Reicher, Sebastian Mafeld, Georgia Priona, Helen L. Reeves, Derek M. Manas, Ralph Jackson, Peter Littler. Early Experience of Trans-arterial Chemo-Embolisation for Hepatocellular Carcinoma with a Novel Radiopaque Bead. CardioVascular and Interventional Radiology 2019; 42(11): 1563 doi: 10.1007/s00270-019-02317-3
|
| 12 |
Xiaohong Li, Xiongfa Ji, Kun Chen, Muhammad Wajid Ullah, Xi Yuan, Zehua Lei, Jiameng Cao, Jun Xiao, Guang Yang. Development of finasteride/PHBV@polyvinyl alcohol/chitosan reservoir-type microspheres as a potential embolic agent: from in vitro evaluation to animal study. Biomaterials Science 2020; 8(10): 2797 doi: 10.1039/C9BM01775E
|
| 13 |
Jonathan Tefera, Lynn Jeanette Savic, Bernhard Gebauer. Kompendium Internistische Onkologie. Springer Reference Medizin 2023; : 1 doi: 10.1007/978-3-662-46764-0_179-1
|
| 14 |
Andrew Tran, Menelaos Konstantinidis, John Moon, Noura El Sehemawi, Katya Ferreira, Peiman Habibollahi, Bruno C Odisio, Sahar Nourouzpour, Ali Bassir, Nariman Nezami. Interventions for unresectable intrahepatic cholangiocarcinoma: a network meta-analysis. Cochrane Database of Systematic Reviews 2022; 2022(12) doi: 10.1002/14651858.CD015159
|
| 15 |
Deniz Tümen, Philipp Heumann, Karsten Gülow, Cagla-Nur Demirci, Lidia-Sabina Cosma, Martina Müller, Arne Kandulski. Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma. Biomedicines 2022; 10(12): 3202 doi: 10.3390/biomedicines10123202
|
| 16 |
Daizo Fukushima, Shigeki Imai, Noriyuki Nishino, Kohichi Hamada, Yoshinori Horikawa, Yoshiki Shiwa, Shinya Nishida, Ryota Koyanagi, Hitoshi Wada, Hideo Sakuma. A case of complete remission of advanced hepatocellular carcinoma with type III portal vein tumor thrombosis treated using transarterial chemoembolization with microspheres and radiation therapy. Clinical Journal of Gastroenterology 2020; 13(5): 847 doi: 10.1007/s12328-020-01124-5
|
| 17 |
Walaa Abdelhamed, Mohamed El-Kassas. Hepatocellular carcinoma recurrence: Predictors and management. Liver Research 2023; 7(4): 321 doi: 10.1016/j.livres.2023.11.004
|
| 18 |
Qinyue Chen, Lan Shu, Yali Sun, Ping Guo, Dong Wang, Xianyi Sha. In Vitro Drug Loading, Releasing Profiles, and In Vivo Embolic Efficacy and Safety Evaluation of a Novel Drug-Eluting Microsphere (CalliSpheres). Cancer Biotherapy and Radiopharmaceuticals 2023; 38(8): 512 doi: 10.1089/cbr.2020.3766
|
| 19 |
Xiaohong Li, Xiongfa Ji, Kun Chen, Xi Yuan, Zehua Lei, Muhammad Wajid Ullah, Jun Xiao, Guang Yang. Preparation and evaluation of ion-exchange porous polyvinyl alcohol microspheres as a potential drug delivery embolization system. Materials Science and Engineering: C 2021; 121: 111889 doi: 10.1016/j.msec.2021.111889
|
| 20 |
Yan Zhang, Mei-Wu Zhang, Xiao-Xiang Fan, Da-Feng Mao, Quan-Hua Ding, Lu-Hui Zhuang, Shu-Yi Lv. Drug-eluting beads transarterial chemoembolization sequentially combined with radiofrequency ablation in the treatment of untreated and recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2020; 12(8): 355-368 doi: 10.4240/wjgs.v12.i8.355
|
| 21 |
Jau-Nan Lin, Jung-Hui Su, Ting-Ying Fu, Shen-Liang Shih. Transarterial chemoembolization as a part of multi-modality treatment with drug-eluting beads for locally advanced breast cancer: A case report. Radiology Case Reports 2021; 16(11): 3383 doi: 10.1016/j.radcr.2021.08.007
|
| 22 |
Dawei Wang, Qirun Wu, Rui Guo, Chennan Lu, Meng Niu, Wei Rao. Magnetic liquid metal loaded nano-in-micro spheres as fully flexible theranostic agents for SMART embolization. Nanoscale 2021; 13(19): 8817 doi: 10.1039/D1NR01268A
|
| 23 |
Antonia M. Berz, Jessica G. Santana, Simon Iseke, Moritz Gross, Vasily Pekurovsky, Fabian Laage Gaupp, Lynn J. Savic, Tabea Borde, Luzie A. Gottwald, Anne Marie Boustani, Bernhard Gebauer, MingDe Lin, Xuchen Zhang, Todd Schlachter, David C. Madoff, Julius Chapiro. Impact of Chemoembolic Regimen on Immune Cell Recruitment and Immune Checkpoint Marker Expression following Transcatheter Arterial Chemoembolization in a VX2 Rabbit Liver Tumor Model. Journal of Vascular and Interventional Radiology 2022; 33(7): 764 doi: 10.1016/j.jvir.2022.03.026
|
| 24 |
Sarah Krieg, Tobias Essing, Andreas Krieg, Christoph Roderburg, Tom Luedde, Sven H. Loosen. Recent Trends and In-Hospital Mortality of Transarterial Chemoembolization (TACE) in Germany: A Systematic Analysis of Hospital Discharge Data between 2010 and 2019. Cancers 2022; 14(9): 2088 doi: 10.3390/cancers14092088
|
| 25 |
V.A. Kondratiuk, I.A. Mazanovych. Endovascular treatment of common hepatocellular carcinoma: the experience of one center. Ukrainian Interventional Neuroradiology and Surgery 2022; 37(3): 57 doi: 10.26683/2786-4855-2021-3(37)-57-61
|
| 26 |
Yanmei Dai, Huijie Jiang, Shi-Ting Feng, Yuwei Xia, Jinping Li, Sheng Zhao, Dandan Wang, Xu Zeng, Yusi Chen, Yanjie Xin, Dongmin Liu. Noninvasive Imaging Evaluation Based on Computed Tomography of the Efficacy of Initial Transarterial Chemoembolization to Predict Outcome in Patients with Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 273 doi: 10.2147/JHC.S351077
|
| 27 |
Gerardo Tovar-Felice, Andrés García-Gámez, Virgilio Benito-Santamaría, David Balaguer-Paniagua, Jordi Villalba-Auñón, Jaume Sampere-Moragues. Unresectable hepatocellular carcinoma treatment with doxorubicin-eluting polyethylene glycol microspheres: a single-center experience. Hepatic Oncology 2021; 8(3) doi: 10.2217/hep-2020-0035
|
| 28 |
Chunpeng He, Wenxin Zeng, Yue Su, Ruowei Sun, Yin Xiao, Bolun Zhang, Wenfang Liu, Rongrong Wang, Xun Zhang, Chuanpin Chen. Microfluidic-based fabrication and characterization of drug-loaded PLGA magnetic microspheres with tunable shell thickness. Drug Delivery 2021; 28(1): 692 doi: 10.1080/10717544.2021.1905739
|
| 29 |
Matthew Walton, Ros Wade, Lindsay Claxton, Sahar Sharif-Hurst, Melissa Harden, Jai Patel, Ian Rowe, Robert Hodgson, Alison Eastwood. Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation. Health Technology Assessment 2020; 24(48): 1 doi: 10.3310/hta24480
|
| 30 |
Aaron Coleman, Elainea N. Smith, Samuel J. Galgano, Kristin K. Porter. Oncologic Imaging : a Multidisciplinary Approach. 2023; : 109 doi: 10.1016/B978-0-323-69538-1.00010-0
|
| 31 |
Alice Hagan, Marcus Caine, Cara Press, Wendy M. Macfarlane, Gary Phillips, Andrew W. Lloyd, Peter Czuczman, Hugh Kilpatrick, Zainab Bascal, Yiqing Tang, Pedro Garcia, Andrew L. Lewis. Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods. European Journal of Pharmaceutical Sciences 2019; 136: 104943 doi: 10.1016/j.ejps.2019.05.021
|
| 32 |
Isabel Schobert, Julius Chapiro, Darko Pucar, Lawrence Saperstein, Lynn Jeanette Savic. Fluorodeoxyglucose PET for Monitoring Response to Embolotherapy (Transarterial Chemoembolization) in Primary and Metastatic Liver Tumors. PET Clinics 2019; 14(4): 437 doi: 10.1016/j.cpet.2019.06.008
|
| 33 |
Suyog Shaha, Danika Rodrigues, Samir Mitragotri. Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation. Journal of Controlled Release 2024; 367: 737 doi: 10.1016/j.jconrel.2024.01.072
|
| 34 |
Mian Khalid, Alisa Likhitsup, Neehar D. Parikh. Embolic and Ablative Therapy for Hepatocellular Carcinoma. Clinics in Liver Disease 2024; doi: 10.1016/j.cld.2024.08.003
|
| 35 |
Xuhua Duan, Hao Li, Donglin Kuang, Pengfei Chen, Mengfan Zhang, Tengfei Li, Dechao Jiao, Yanliang Li, Xiang He, Cheng Xing, Haibo Wang, Yaoxian Liu, Limin Xie, Shixi Zhang, Qiang Zhang, Peixin Zhu, Yongchuang Chang, Jichen Xie, Jianzhuang Ren, Xinwei Han. Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-02012-x
|
| 36 |
Murtuza Razi, Gu Jianping, He Xu, Mohammed Jameeluddin Ahmed. Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma. Journal of Interventional Medicine 2021; 4(1): 11 doi: 10.1016/j.jimed.2020.10.006
|
| 37 |
Kensuke Yamamura, Toru Beppu, Nobutaka Sato, Eri Oda, Koichi Kinoshita, Hideaki Yuki, Toshihiko Motohara, Hideaki Miyamoto, Tsutomu Oda, Shinichi Akahoshi. Huge hepatocellular carcinoma with extrahepatic collateral arteries successfully treated by multidisciplinary treatment including laparoscopic devascularization: a case report. Clinical Journal of Gastroenterology 2021; 14(1): 251 doi: 10.1007/s12328-020-01286-2
|
| 38 |
Min He, Jia-Bin Cai, Can Lai, Jun-Qing Mao, Jie-Ni Xiong, Zhong-Hai Guan, Lin-Jie Li, Qiang Shu, Mei-Dan Ying, Jin-Hu Wang. Neoadjuvant transcatheter arterial chemoembolization and systemic chemotherapy for the treatment of undifferentiated embryonal sarcoma of the liver in children. World Journal of Clinical Cases 2022; 10(19): 6437-6445 doi: 10.12998/wjcc.v10.i19.6437
|
| 39 |
Carolina Lanza, Serena Carriero, Pierpaolo Biondetti, Salvatore Alessio Angileri, Gianpaolo Carrafiello, Anna Maria Ierardi. Advances in Imaging Guidance During Percutaneous Ablation of Renal Tumors. Seminars in Ultrasound, CT and MRI 2023; 44(3): 162 doi: 10.1053/j.sult.2023.03.003
|
| 40 |
Salvatore Alessio Angileri, Carolina Lanza, Serena Carriero, Pierpaolo Biondetti, Velio Ascenti, Giuseppe Pellegrino, Alessandro Caruso, Gianpaolo Carrafiello, Anna Maria Ierardi. Performance and Safety of a Reflux-Control Microcatheter Used to Perform DEB-TACE with LUMITM Beads in HCC Patients: Preliminary Experience. Journal of Clinical Medicine 2023; 12(20): 6630 doi: 10.3390/jcm12206630
|
| 41 |
Camillo Aliberti, Riccardo Carandina, Donatella Sarti, Enrico Pizzirani, Gaetano Ramondo, Umberto Cillo, Stefano Guadagni, Giammaria Fiorentini. Transarterial chemoembolization with DC Bead LUMI™ radiopaque beads for primary liver cancer treatment: preliminary experience. Future Oncology 2017; 13(25): 2243 doi: 10.2217/fon-2017-0364
|
| 42 |
Chia-Ying Lin, Yi-Sheng Liu, Kuang-Tse Pan, Chia-Bang Chen, Chein-Fu Hung, Chen-Te Chou. The short-term safety and efficacy of TANDEM microspheres of various sizes and doxorubicin loading concentrations for hepatocellular carcinoma treatment. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91021-9
|
| 43 |
Yinbao Hu, Zhangping Zhao, Songwei Li, Xingming Xu, Ying Xie, Dong Yan, Youjian Zou, Hui Liu. Investigation of the Physical Properties and Clinical Application of Embosphere Microspheres. Chemotherapy 2021; 66(4): 139 doi: 10.1159/000517680
|
| 44 |
|
| 45 |
Sarah Hamidi, Armeen Mahvash, Mimi I Hu. Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver Metastases. JCEM Case Reports 2024; 2(8) doi: 10.1210/jcemcr/luae103
|
| 46 |
|
| 47 |
M.-C. Ou, Y.-S. Liu, M.-T. Chuang, C.-Y. Lin, L.-T. Huang, C.-Y. Lin. Time-to-progression following conventional compared with drug-eluting-bead transcatheter arterial chemoembolisation in patients with large hepatocellular carcinoma. Clinical Radiology 2019; 74(4): 295 doi: 10.1016/j.crad.2018.12.008
|
| 48 |
Yang-Feng Lv, Zhi-Qiang Deng, Qiu-Chen Bi, Jian-Jun Tang, Hong Chen, Chuan-Sheng Xie, Qing-Rong Liang, Yu-Hua Xu, Rong-Guang Luo, Qun Tang. Intratumoral Pi deprivation benefits chemoembolization therapy via increased accumulation of intracellular doxorubicin. Drug Delivery 2022; 29(1): 1743 doi: 10.1080/10717544.2022.2081384
|
| 49 |
Cody R. Criss, Mina S. Makary. Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors. Biology 2023; 12(7): 999 doi: 10.3390/biology12070999
|
| 50 |
Kelley G. Núñez, Tyler Sandow, Daniel Fort, Jai Patel, Mina Hibino, Ian Carmody, Ari J. Cohen, Paul Thevenot. Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma. Cancers 2021; 13(19): 4765 doi: 10.3390/cancers13194765
|
| 51 |
Isabel Theresa Schobert, Lynn Jeanette Savic, Julius Chapiro, Khaled Bousabarah, Evan Chen, Fabian Laage-Gaupp, Jonathan Tefera, Nariman Nezami, MingDe Lin, Jeffrey Pollak, Todd Schlachter. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. European Radiology 2020; 30(10): 5663 doi: 10.1007/s00330-020-06931-5
|
| 52 |
Jannatul Fardous, Yuji Omoso, Akshat Joshi, Kozue Yoshida, Md Kawchar Ahmed Patwary, Fumiyasu Ono, Hiroyuki Ijima. Development and characterization of gel-in-water nanoemulsion as a novel drug delivery system. Materials Science and Engineering: C 2021; 124: 112076 doi: 10.1016/j.msec.2021.112076
|
| 53 |
Nur Aisyah Nuzulia, Terry Mart, Ifty Ahmed, Yessie Widya Sari. The Use of Microspheres for Cancer Embolization Therapy: Recent Advancements and Prospective. ACS Biomaterials Science & Engineering 2024; 10(2): 637 doi: 10.1021/acsbiomaterials.3c00659
|
| 54 |
Isabelle Mohr, Marie Vogeler, Jan Pfeiffenberger, Simon David Sprengel, Miriam Klauss, Boris Radeleff, Andreas Teufel, De-Hua Chang, Christoph Springfeld, Thomas Longerich, Uta Merle, Arianeb Mehrabi, Karl Heinz Weiss, Markus Mieth. Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2022; 148(11): 3163 doi: 10.1007/s00432-021-03900-3
|
| 55 |
Hui Li, Fucang Wu, Min Duan, Guodong Zhang. Drug-eluting bead transarterial chemoembolization (TACE) vs conventional TACE in treating hepatocellular carcinoma patients with multiple conventional TACE treatments history. Medicine 2019; 98(21): e15314 doi: 10.1097/MD.0000000000015314
|
| 56 |
Xiaohong Li, Muhammad Wajid Ullah, Basen Li, Hangrong Chen. Recent Progress in Advanced Hydrogel‐Based Embolic Agents: From Rational Design Strategies to Improved Endovascular Embolization. Advanced Healthcare Materials 2023; 12(17) doi: 10.1002/adhm.202202787
|
| 57 |
Guorong Jia, Juno Van Valkenburgh, Austin Z. Chen, Quan Chen, Jindian Li, Changjing Zuo, Kai Chen. Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma. WIREs Nanomedicine and Nanobiotechnology 2022; 14(2) doi: 10.1002/wnan.1749
|
| 58 |
Zhen Li, Du Xiao, Xin Li, Pengchao Zhan, Jiaxiang Wang, Henghui Zhang. Early recurrence detected in hepatocellular carcinoma patients after transcatheter arterial chemoembolization treatment with plasma cell-free DNA. European Journal of Gastroenterology & Hepatology 2019; 31(7): 885 doi: 10.1097/MEG.0000000000001373
|
| 59 |
Qinyue Chen, Yali Sun, Haixue Dai, Ping Guo, Shuangxing Hou, Xianyi Sha. Assessment of Irinotecan Loading and Releasing Profiles of a Novel Drug-Eluting Microsphere (CalliSpheres) In Vitro. Cancer Biotherapy and Radiopharmaceuticals 2023; 38(8): 521 doi: 10.1089/cbr.2020.3805
|
| 60 |
Ping Wen, Sheng-Duo Chen, Jia-Rui Wang, Ying-He Zeng. Comparison of Treatment Response and Survival Profiles Between Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Chinese Hepatocellular Carcinoma Patients: A Prospective Cohort Study. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2019; 27(5): 583 doi: 10.3727/096504018X15368325811545
|
| 61 |
Roberto Iezzi, Alessandro Posa, Andrea Contegiacomo, In Joon Lee, Reto Bale, Alessandro Tanzilli, Lorenzo Tenore, Felice Giuliante, Antonio Gasbarrini, Shraga Nahum Goldberg, Tobias Jakobs, Maurizio Pompili, Irene Bargellini, Evis Sala, Hyo-Cheol Kim. Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives. Cancers 2023; 15(15): 3988 doi: 10.3390/cancers15153988
|
| 62 |
Nancy Kemeny, Ieva Kurilova, Jia Li, Juan C. Camacho, Constantinos T. Sofocleous. Liver-Directed and Systemic Therapies for Colorectal Cancer Liver Metastases. CardioVascular and Interventional Radiology 2019; 42(9): 1240 doi: 10.1007/s00270-019-02284-9
|
| 63 |
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations. Journal of Clinical and Experimental Hepatology 2024; 14(1): 101269 doi: 10.1016/j.jceh.2023.08.005
|
| 64 |
Roshana Saghafian Larijani, Nazanin Shabani Ravari, Navid Goodarzi, Shahram Akhlaghpour, Samaneh Saghafian Larijani, Mohammad Reza Rouini, Rassoul Dinarvand. Current status of transarterial chemoembolization (TACE) agents in hepatocellular carcinoma treatment. Journal of Drug Delivery Science and Technology 2022; 77: 103905 doi: 10.1016/j.jddst.2022.103905
|
| 65 |
Mina S. Makary, Jonathan Alexander, Luis E. Regalado, Sajid Jalil, Khalid Mumtaz, Jincheng Wang. Clinical outcomes of DEB-TACE in locally advanced hepatocellular carcinoma: A 5-year real world experience. PLOS ONE 2024; 19(9): e0309693 doi: 10.1371/journal.pone.0309693
|
| 66 |
Jun Zhao, Yan-shu Li, Zhi-Xing Liu, Mu-Hua Huang, Yu-hua Xu, Qing-rong Liang, Li Chen, Rong-guang Luo, Qun Tang. Nanosized drug-eluting bead for transcatheter arterial chemoembolization (ND-TACE). Journal of Materials Chemistry B 2020; 8(37): 8684 doi: 10.1039/D0TB01295E
|
| 67 |
Faraaz Khan, Keaton Jones, Paul Lyon. Immune checkpoint inhibition: a future guided by radiology. The British Journal of Radiology 2023; doi: 10.1259/bjr.20220565
|
| 68 |
Lin Li, Wenzhuo Zhao, Mengmeng Wang, Jie Hu, Enxin Wang, Yan Zhao, Lei Liu. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0849-0
|
| 69 |
Erin A. Gibson, Roger E. Goldman, William T. N. Culp. Comparative Oncology: Management of Hepatic Neoplasia in Humans and Dogs. Veterinary Sciences 2022; 9(9): 489 doi: 10.3390/vetsci9090489
|
| 70 |
Pierpaolo Biondetti, Carolina Lanza, Serena Carriero, Francesca Arrigoni, Margherita Bevilacqua, Aurora Ruffino, Sonia Triggiani, Adriana Sorce, Andrea Coppola, Anna Maria Ierardi, Massimo Venturini, Giuseppe Guzzardi, Gianpaolo Carrafiello. Efficacy and Safety of Transarterial Chemoembolization with DC Beads LUMI in the Treatment of HCC: Experience from a Tertiary Centre. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231184840
|
| 71 |
Khaled Farid, Hatem Elalfy, Salwa M. Abo El-khair, Hoda Elgamal, Tarek Besheer, Ali Elmokadem, Walaa Shabana, Sally Abed, Mohamed Elegezy, Ahmed Abd El-khalek, Ahmed El-Morsy, Amr Negm, Ayman Z. Elsamanoudy, Basem El deek, Talal Amer, Mahmoud El-Bendary. Prognostic value of vascular endothelial growth factor in both conventional and drug eluting beads transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma in HCV patients. Expert Review of Gastroenterology & Hepatology 2020; 14(12): 1203 doi: 10.1080/17474124.2020.1823215
|
| 72 |
Şükran Alpdemir, Tayfun Vural, Göknur Kara, Cem Bayram, Erdem Haberal, Emir Baki Denkbaş. Magnetically responsive, sorafenib loaded alginate microspheres for hepatocellular carcinoma treatment. IET Nanobiotechnology 2020; 14(7): 617 doi: 10.1049/iet-nbt.2020.0139
|
| 73 |
Anant Ramaswamy, Akash Shukla, Reena Engineer, Sridhar Sundaram, Sujay Srinivas, Suyash Kulkarni, Shraddha Patkar, Sanjay Baijal, Aditya Kale, Akhil Kapoor, Amar Mukund, Amit Choudhari, Amit Rauthan, Ashwathy Susan Mathew, Rushi Panchal, Kausik Bhattacharya, Prachi Patil, Nitin Shetty, Kunal Gala, Lijesh Kumar, Deepashree Thiruchunapalli, Naveen Kalra, Tarini Prasad Sahoo, M Vamshi Krishna, Viraj Lavingia, Ravi Mohanka, Vineet Talwar, Vikas Ostwal, Prabhat Bhargava, Jyoti Poddar, Amit Singal, Mahesh Goel. Evaluation and Management of Unresectable Hepatocellular Carcinoma: Multidisciplinary Indian Consensus Statements from a Delphi Panel. South Asian Journal of Cancer 2024; doi: 10.1055/s-0044-1788569
|
| 74 |
Kai-Hsiang Chang, Zhen-An Hwang, Ping-Ying Chang, Hsuan-Hwai Lin, Yu-Lueng Shih, Wei-Chou Chang, Guo-Shu Huang, Hsian-He Hsu. Predictive imaging for tumor response to drug-eluting microsphere transarterial chemoembolization in patients with BCLC-C advanced hepatocellular carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-56545-1
|
| 75 |
In-Jung Kim, Sung Hwan Yoo, Jung Il Lee, Kwan Sik Lee, Hyun Woong Lee, Jin Hong Lim. Long-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case report. Journal of Liver Cancer 2022; 22(1): 84 doi: 10.17998/jlc.2022.03.07
|
| 76 |
Duk-Ju Kim, In Chul-Nam, Sung-Eun Park, Doo-Ri Kim, Jeong-Sub Lee, Bong-Soo Kim, Guk-Myung Choi, JeongJae Kim, Jung-Ho Won. Added Value of Cone-Beam Computed Tomography for Detecting Hepatocellular Carcinomas and Feeding Arteries during Transcatheter Arterial Chemoembolization Focusing on Radiation Exposure. Medicina 2023; 59(6): 1121 doi: 10.3390/medicina59061121
|
| 77 |
. Experimental and Clinical Transplantation 2018; doi: 10.6002/ect.2018.0017
|
| 78 |
Kai-Cai Liu, Wei-Fu lv, Dong Lu, Chang-Long Hou, Jun Xie, Yu-He Lu, Qi-Sheng Cao, Yu-Lin Tan, Ying-Zhan Zhang, Jie Liu. Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma. Cancer Management and Research 2021; : 7973 doi: 10.2147/CMAR.S332571
|
| 79 |
Kurt Zacharias, Osman Ahmed. Diagnosis and Management of Endocrine Disorders in Interventional Radiology. 2022; : 315 doi: 10.1007/978-3-030-87189-5_20
|
| 80 |
Yuxin Liang, Zilong Zhang, Deyuan Zhong, Chunyou Lai, Zonglin Dai, Haibo Zou, Tianhang Feng, Jin Shang, Ying Shi, Xiaolun Huang. The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.913731
|
| 81 |
Iveta Urban, Florian Primavesi, Klaus Bogner, Claudia Bartsch, Marlene Trattner, Alexandra Schmid, Stefan Stättner. Hepatocellular carcinoma—neoadjuvant systemic and local treatment concepts to improve resectability rates and oncological outcome. memo - Magazine of European Medical Oncology 2022; 15(1): 5 doi: 10.1007/s12254-021-00791-5
|